An Oxford University-led trial testing a commonly available immunosuppressive drug on COVID-19 patients has found the cheap steroid significantly reduces deaths when administered to severely sick patients in intensive care. The treatment, described as ...
from Google Alert - health https://ift.tt/3hVoJCS
via IFTTT
0 comments:
Post a Comment